Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Baxano Surgical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 29.81M 26.15M 19.15M 14.57M 18.58M
Cost of Goods Sold (COGS) incl. D&A 5.69M 7.1M 4.56M 4.31M 5.64M
COGS excluding D&A 4.78M 6.36M 3.89M 3.17M 3.6M
Depreciation & Amortization Expense 909,000 746,000 662,000 1.14M 2.04M
Depreciation 909,000 746,000 662,000 1.14M 1.7M
Amortization of Intangibles 0 0 0 0 338,000
Gross Income 24.12M 19.05M 14.6M 10.26M 12.94M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 47.72M 39.06M 32.88M 31.68M 40.63M
Research & Development 6.44M 4.22M 5.19M 5.46M 6.92M
Other SG&A 41.28M 34.84M 27.69M 26.22M 33.71M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 8.32M 3.99M
EBIT after Unusual Expense 0 0 0 (8.32M) (3.99M)
Non Operating Income/Expense 0 0 0 (147,000) 16,000
Non-Operating Interest Income 405,000 486,000 6,000 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 0 0 0 374,000
Gross Interest Expense 0 0 0 0 374,000
Interest Capitalized - 0 0 0 0
Pretax Income (23.2M) (19.53M) (18.27M) (29.89M) (32.03M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (23.2M) (19.53M) (18.27M) (29.89M) (32.03M)
Minority Interest Expense 0 0 0 0 0
Net Income (23.2M) (19.53M) (18.27M) (29.89M) (32.03M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (23.2M) (19.53M) (18.27M) (29.89M) (32.03M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (23.2M) (19.53M) (18.27M) (29.89M) (32.03M)
EPS (Basic) (1.13) (0.94) (0.81) (1.10) (0.85)
Basic Shares Outstanding 20.6M 20.74M 22.59M 27.27M 37.9M
EPS (Diluted) (1.13) (0.94) (0.81) (1.10) (0.85)
Diluted Shares Outstanding 20.6M 20.74M 22.59M 27.27M 37.9M
EBITDA (22.69M) (19.27M) (17.62M) (20.28M) (25.64M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.